Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-DC011313 | Panoply™ Human PARP10 Knockdown Stable Cell Line | Inquiry |
| CSC-SC011313 | Panoply™ Human PARP10 Over-expressing Stable Cell Line | Inquiry |
| CSC-RT2215 | Human PARP10 Knockout Cell Line-A549 | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| AD11821Z | Human PARP10 adenoviral particles | Inquiry |
| LV21001L | human PARP10 (NM_032789) lentivirus particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHH370824 | shRNA set against Human PARP10 (NM_032789.3) | Inquiry |
| SHH370828 | shRNA set against Mouse PARP10 (NM_001163575.1) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| CDCL146019 | Human PARP10 ORF clone (NM_032789.3) | Inquiry |
| CDCR239925 | Mouse Parp10 ORF Clone(NM_001163575.1) | Inquiry |
| CDCR239927 | Mouse Parp10 ORF Clone(NM_001163576.1) | Inquiry |
| CDFG019663 | Mouse Parp10 cDNA Clone(NM_001163575.1) | Inquiry |
| CDFG019665 | Mouse Parp10 cDNA Clone(NM_001163576.1) | Inquiry |
| MiUTR1H-07518 | PARP10 miRNA 3'UTR clone | Inquiry |
As a member of the PARP family, which performs mono-ADP-ribosylation of target proteins, poly (ADP-ribose) polymerase (PARP10) was demonstrated to have some linkages with metabolic processes and metabolic regulators, which may give a hint that PARP10 may have influences on mitochondrial oxidative metabolism. In cellular models of breast, cervical, colorectal and exocrine pancreas cancer, specific shRNAs mediated PARP10 knockout can increase mitochondrial oxidative capability. Mitochondrial superoxide production decrease induced by silencing of PARP10 is in accordance with increased expression of antioxidant genes. However, mitochondrial oxidative capacity was found to have a relationship with increased AMPK activation. In MCF7 and CaCo2 cells, silencing of PARP10 can decrease the proliferation rate linked with increased expression of anti-Warburg enzyme. The fact that lower PARP10 expression increases survival in gastric cancer can be analyzed from the online database.
It is known that the exposition of cells in carcinogenesis to the increased replication stress was the result of the replication fork arrest as sites of DNA lesions and difficulty to replicate genomic regions. Efficient fork restart and DNA repair have a significant role in cancer cell proliferation. Interactions between ADP-ribosyltransferase PARP10 and the replication protein were demonstrated in the previous studies to promote lesion bypass by the recruitment of specialized, non-replicative DNA polymerases. In a large proportion of human tumors, PARP10 was found to be over-expressed. In order to fully reveal the role of PARP10 in cellular transformation, inactivation of PARP10 by CRISPR/Cas9 in Hela cancer cells, and overexpression of it in non-transformed RPE-1 cells were deployed. And it found that cellular proliferation can be promoted by PARP10, whose overexpression has relations with alleviation of cellular sensitivity to replication stress and restart of stalled replication forks. Loss of PARP10 in the xenograft models can reduce the tumorigenesis activity of Hela cells, however, overexpression gives rise to tumor formation by non-transformed RPE-1 cells. PARP10 was indicated to the role as a promoter for cellular transformation through alleviating the replication stress.
Figure 1. A chemical genetics strategy for generating selective inhibitors of PARP10. (Rory K Morgan, et al. 2015)
References: